Diagonal Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 03, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $128,000,000
Company Info
- Founders
- Alex Lugovskoy
- Company Description
- Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies.
- Market
- Biopharmaceuticals
- Location
- Cambridge, MA, USA
- Coinvestors
- Atlas Venture, BVF Partners, Checkpoint Capital, Frazier Life Sciences, Lightspeed Venture Partners, RA Capital Management, Velosity Capital, Viking Global Investors